top of page
GALA-25-01 Header Banner_v1.jpg
GALA-25-01 Title Lockup_v3.png

May 16-17, 2025

The Westin Dallas Southlake

Southlake, Texas

SOCIETY ENDORSEMENTS

NTSGNA_highres.png
TSGE logo.png

COURSE DIRECTORS

Faculty
Mitchell.jpg

Mack Mitchell, MD

Vice President for Medical Affairs
University of Texas Southwestern
Medical Center
Dallas, Texas

Schiller.jpg

Lawrence Schiller, MD

Chair, Institutional Review Boards
Baylor University Medical Center
Dallas, Texas

FACULTY

Abraham.jpg

Bincy Abraham, MD

Houston Methodist Hospital

Houston, Texas

Abraham.jpg

Stephen Hanauer, MD

Northwestern University

Chicago, Illinois

Abraham.jpg

William Lee, MD

UT Southwestern Medical Center

Dallas, Texas

Abraham.jpg

Jackie O'Leary, MD

UT Southwestern Medical Center

Dallas, Texas

Abraham.jpg

William Chey, MD

University of Michigan

Ann Arbor, Michigan

Abraham.jpg

Jana Hashash, MD

Mayo Clinic

Jacksonville, Florida

Abraham.jpg

Ildiko Lingvay, MD

UT Southwestern Medical Center

Dallas, Texas

Abraham.jpg

Nancy Reau, MD

Rush University Medical Center

Chicago, Illinois

Abraham.jpg

Paul Feuerstadt, MD

Yale School of Medicine

New Haven, Connecticut

Abraham.jpg

Eric Lawitz, MD

The Texas Liver Institute

San Antonio, Texas

Abraham.jpg

Marlyn Mayo, MD

UT Southwestern Medical Center

Dallas, Texas

Abraham.jpg

Amit Singal, MD

UT Southwestern Medical Center

Dallas, Texas

Spechler.jpg

Stuart Spechler, MD

Baylor University Medical Center

Dallas, Texas

Stidham.jpg

Ryan Stidham, MD

University of Michigan

Ann Arbor, Michigan

Agenda

AGENDA

Friday, May 16, 2025
 

11:30 AM              
Lunch and Registration

 

12:00 PM - 12:45 PM

Strive Towards Treatment Goals

Anish Patel, DO

Industry-Sponsored Event (Non-accredited)

Sponsored by Eli Lilly & Company 

 

12:50 PM - 1:05 PM                  
Program Overview

 
Session I

 

1:05 PM - 1:30 PM                 

Artificial Intelligence in the Clinic and Endoscopy Laboratory

Ryan Stidham, MD 

​
1:30 PM - 1:55 PM                        

Microbiome Therapeutics 

Paul Feuerstadt, MD

​​​

1:55 PM - 2:20 PM                   

Primary Biliary Cholangitis (PBC): New Treatment Options

Marlyn Mayo, MD


2:20 PM - 2:35 PM                        
Q&A
/ Panel Discussion

 

2:35 PM – 2:50 PM                  
Break

Session II

​

2:50 PM - 3:15 PM                        

New and Emerging Treatments for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Eric Lawitz, MD​

​

​3:15 PM - 3:40 PM                      

What is Metabolic / Alcohol-associated Liver Disease (MetALD)?

Mack Mitchell, MD

​

3:40 PM - 4:10 PM                        

Updates on the Management of Hepatocellular Carcinoma

Amit Singal, MD ​​

​

4:10 PM - 4:30 PM                  
Q&A / Panel Discussion

​​​​

4:30 PM – 5:30 PM  
Light reception (15 minutes) followed by:
Industry-Sponsored Event (Non-accredited)

TREMFYA® (guselkumab): Now Approved in Adults with Moderately to Severely Active Crohn’s Disease

Harry Thomas, MD            

Sponsored by Johnson & Johnson
 

5:30 PM - 7:00 PM                        
Reception

​

Saturday, May 17, 2025
​

7:15 AM              

Breakfast and Registration

​

7:30 AM - 8:15 AM 

Clinical Deep Dive:  Unlocking the Treatment Potential of Rezdiffra

Nadege Gunn, MD

Industry-Sponsored Event (Non-accredited)

Sponsored by Madrigal Pharmaceuticals

​

8:20 AM – 8:25 AM                  
Program Overview

​

Session III
 

8:25 AM – 8:55 AM                 
Diagnosis and Management of Cyclic Vomiting Syndrome and Cannabis Hyperemesis Syndrome

Lawrence Schiller, MD

8:55 AM - 9:25 AM       

Management of Helicobacter Pylori

William Chey, MD


9:25 AM - 9:55 AM                   
Integrating Potassium-Competitive Acid Blockers (PCABs) Into Clinical Practice

Stuart Spechler, MD

​

​9:55 AM - 10:20 AM                  
Q&A / Panel Discussion


10:20 AM – 10:35 AM              
Break

 

10:35 AM - 11:35 AM              
Parallel Session (Select One)

  • GI Woes from Head to Toe

  • Inflammatory Bowel Disease

  • Steatotic Liver Disease and Viral Hepatitis

  • Chronic Liver Disease
     

11:35 AM - 11:50 AM                 
Lunch Break

 

11:50 AM - 12:35 PM     

Eosinophilic Esophagitis: Clinical Implications of Disease Progression

Gary Falk, MD, MS

Industry-Sponsored Event (Non-accredited)
Sponsored By Sanofi | Regeneron 


​

Session IV


12:35 PM - 1:05 PM                      
Managing the Obesity Epidemic

Ildiko Lingvay, MD

​

1:05 PM - 1:35 PM                        

Acute-on-Chronic Liver Failure and the Management of Critically Ill Patients With Cirrhosis 
Jackie O'Leary, MD

​

1:35 PM - 2:00 PM                        

Risk Stratification and Management of Portal Hypertension and Varices in Cirrhosis:
Understanding the New AASLD Practice Guidance

Nancy Reau, MD

​              

2:00 PM - 2:25 PM  

Hepatitis B and D: Natural History and Treatment

William Lee, MD

2:25 PM - 2:40 PM               
Q&A / Panel Discussion

2:40 PM - 2:50 PM                        
Break

 

Session V

2:50 PM - 3:20 PM                        

Simplifying the Treatment Algorithm for Moderate-Severe Inflammatory Bowel Disease (IBD): A Practical Approach

Stephen Hanauer, MD 

​

3:20 PM - 3:50 PM                      
Point of Care IUS in the Management of IBD

Bincy Abraham, MD

​

3:50 PM - 4:20 PM

Diet & Nutritional Therapy for IBD

Jana Al Hashash, MD
              
4:20 PM - 4:35 PM                        
Q&A / Panel Discussion

4:35 PM - 4:45 PM                    
Meeting Wrap-up

Venue

VENUE

The Westin
Dallas Southlake

1200 E. State HWY 114
Southlake, TX 76092

hotel-exterior_edited_edited_edited_edited.png

Subscribe to get GALA updates!

Thanks for subscribing!

Subscribe
  • Facebook
  • LinkedIn
bottom of page